Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Triangle Pharmaceuticals presents preliminary data on FTC in HBV patients

Nov. 18, 1998

Study completed on new therapy for traveler's diarrhea

Nov. 18, 1998

Gilead's adefovir dipivoxil extensively covered at AASLD meeting

Nov. 17, 1998

Pegylated interferon proves superior to standard interferon for treatment of HCV

Nov. 16, 1998

Data presented at AASLD indicate role for caspase inhibitors in liver transplantation

Nov. 16, 1998

Antiulcer tetrahydropyrido compounds in development at Byk Gulden

Nov. 16, 1998

Bristol-Myers Squibb initiates phase III HBV clinical trials; phase II data reported

Nov. 13, 1998

Heptazyme demonstrates potent activity against HCV

Nov. 12, 1998

KGF-2 shows promise for treating IBD

Nov. 12, 1998

Inhibition of cytokine production contributes to the antiinflammatory activity of orazipone

Nov. 11, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...